Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
نویسنده
چکیده
CLINICAL INTERmNTION AND THERAPEUTIC TRLALS The Effect of a-Interferon on Bone Marrow Megakaryocytes and Platelet Production Rate in Essential Thrombocythemia .................. H. Wadenvik, J. Kutti, B. Ridell, P. Revesz, S. Jacobsson, B. Magnumon, J. Westin, and L. El& Combined Therapy With Recombinant Granulocyte Colony-Stimulating Factor and Erythropoietin Decreases Hematologic Toxicity From Zidovudine ............. S.A. Miles, R. T. Mitsuyasu, J. Moreno, G. Baldwin, N.K. Alton, L. Souza, and J.A. Glaspy
منابع مشابه
Hodgkin\'s Disease
SUMMARY Hodgkin's disease has been known to medical practitioners for more than three centuries. The clinical and pathologic description of the disease published by Thomas. Hodgkin first in 183 2 when reported seven cases th-at he considered a new clinical entity. The incident, clinical feature, histologic, procedure of evaluation and staging of Hodgkin's disease are presented briefly. Part...
متن کاملAUTOLOGOUS MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP AND ABVD-RESI STANT HODGKIN\'S DISEASE
Six patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine and prednisolone), and ABVD (adriamycin, bleomycin, vinblastine and dacarbazine) chemotherapy were treated with high-dose chemotherapy and autologous marrow transplantation. The patients first underwent marrow aspiration and storage for subsequent autologous bone marrow transplant...
متن کاملCurrent treatment and immunotherapy of Hodgkin's lymphoma.
The treatment of Hodgkin's lymphoma has changed significantly over the last decades, rendering this entity one of the most curable human cancers. To date, about 80% of patients achieve long-term disease-free survival. Current strategies in first-line treatment aim at further improving outcome and thereby preventing therapy-induced complications, such as infertility, cardiopulmonary toxicity, an...
متن کاملHodgkin's Lymphoma: Choice of Therapy and Late Complications.
This review focuses on the different treatment options available for the treatment of Hodgkin's disease, with an emphasis on the importance of the long-term sequelae of these therapies. In Section I, Dr. Linch reviews the current status of Hodgkin's disease treatment. Survival rates have improved over the last three decades due both to better initial therapies and associated supportive care and...
متن کاملExtreme Hodgkin's lymphoma: current problem areas.
In Hodgkin's lymphoma therapy, there remain areas of extreme difficulty. This article briefly explores these areas and provides evidence that risk-related therapy and web-based data collection programmes can facilitate progress. Unpublished data from the northern region of the UK suggest that risk-based therapy among poor-prognosis Hodgkin's lymphoma patients aged 15-19 years is improving outco...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 77 10 شماره
صفحات -
تاریخ انتشار 1991